Professional Documents
Culture Documents
Takeyoshiminaga1978 PDF
Takeyoshiminaga1978 PDF
BBA 213414
T A K E Y O S H I M I N A G A , M A N O H A R L. S H A R M A , E R N E S T K U N * and W A L T E R N.
PIPER *
Summary
Introduction
700-
#' '7,o\
"~ 3 5 0
36 12 24 48 72
Time of incubation(minutes)
Fig. 1. A p p a r e n t r a t e s o f p r o d u c t f o r m a t i o n f r o m s u c c i n y l - C o A as a f u n c t i o n o f t i m e o f i n c u b a t i o n w i t h
l i v e r h o m o g e n a t e . L i v e r h o m o g e n a t e ( 2 0 0 ~ g p r o t e i n ) w a s i n c u b a t e d in t h e p r e s e n c e o f 1 0 0 m M T t i s o
HC1, p H 7.4, 1 0 0 ~ M p y r i d o x a l p h o s p h a t e ~ 10 m M E D T A a n d 1 0 0 / ~ M [ 1 4 C ] s u c c i n y t - C o A (9.1 ,,zCi) w i t h
1 0 0 m M g l y c i n e (o --e) o r w i t h o u t g l y c i n e (o . . . . . . o). T h e p r o d u c t w a s i s o l a t e d a n d d e t e r m i n e d as
described i n M a t e r i a l s a n d M e t h o d s .
421
O
J50- j ~je
.c
E
ro
75 "-
-5
/O/°
,~o I I I J
50 I00 200 400
.~g protein
Fig. 2. L i n e a r r e l a t i o n s h i p b e t w e e n r a t e s o f p r o d u c t f o r m a t i o n a n d c o n c e n t r a t i o n o f l i v e r h o m o g e n a t e .
V a r y i n g a m o u n t s o f l i v e r h o m o g e n a t e w e r e i n c u b a t e d in t h e p r e s e n c e o f 1 0 0 m M Tris • HC1, p H 7.4, 1 0 0
p M p y r i d o x a l p h o s p h a t e , 1 0 m M E D T A , 1 0 0 m M g l y c i n e a n d 1 0 0 p M [ 1 4 C ] s u c c i n y l - C o A (0.1 pCi) f o r
3 r a i n at 30°C. ,The p r o d u c t w a s i s o l a t e d a n d d e t e r m i n e d as d e s c r i b e d in Materials a n d M e t h o d s .
TABLE I
P Y R R O L E F O R M A T I O N F R O M ~ - A M I N O L E V U L I N I C ACID AND ITS ABSENCE IN T H E ENZY-
MATIC P R O D U C T S OF SUCCINYL-CoA OR S U C C I N A T E
2 5 0 # M (1 /~Ci) [ 1 4 C ] s u c c i n a t e w a s i n c u b a t e d in 2 m l v o l u m e s w i t h 10 m g ( p r o t e i n liver h o m o g e n a t e , 50
m M Tris • HC1 b u f f e r ( p H 7.3), 1 0 0 p M p y r i d o x a l p h o s p h a t e , 1 0 m M E D T A a n d 20 m M MgC12 (cf. ref.
1 3 ) in t h e a b s e n c e a n d p r e s e n c e o f 1 0 0 m M glycine. A f t e r i n c u b a t i o n f o r 5 rain (at 3 0 ° C ) t h e r e a c t i o n w a s
t e r m i n a t e d b y 1 m l 15% t r i c h l o r o a c e t i c acid a n d c h r o m a t o g r a p h i c p r o c e d u r e s o n D o w e x 50 w e r e per-
f o r m e d as d e s c r i b e d in Materials a n d M e t h o d s . T h e final e l u a t e s w i t h N H 4 O H f r o m t h e c o l u m n s w e r e l y o -
p h i l i z e d a n d a d j u s t e d to p H 4 . 6 w i t h 1 M s o d i u m a c e t a t e b u f f e r . A e e t y l a c e t o n e ( 2 0 0 p l ) w a s a d d e d a n d
t h e m i x t u r e i m m e r s e d in a b o i l i n g w a t e r b a t h f o r 20 rain. A f t e r c o o l i n g , t h e 8 - a m i n o l e v u l i n i c a c i d - p y r r o l e
w h e n present was extracted f r o m the aqueous phase into ethyl acetate. Authentic 5-amino[ 14]levulinic
acid w a s p r e s e n t in c o n t r o l s . E a c h v a l u e r e p r e s e n t s t h e a v e r a g e o f t h r e e e x p e r i m e n t s .
S o l v e n t :phase 5 - A m i n o [ 14 ] . 14 C-labelled p r o d u c t f r o m :
levulinic acid
[ 14 C] S u e e l n y l - C o A [ 14 C ] S u c c i n a t e -
. o
wO 50
-~
~ I~ IO-~M pheny[mefhytsulfonylfluodde
I~~ ........... ~:
0,5 a.O 2-0
mg protein
Fig. 3. I n h i b i t i o n o f p r o d u c t f o r m a t i o n f r o m s u c c i n y l - C o A b y p h e n y l m e t h y l s u l f o n y l ~ u o r i d e . V a r y i n g
a m o u n t s o f l i v e r h o m o g e n a t e w e r e i n c u b a t e d f o r 3 r a i n i n t h e p r e s e n c e o f i 0 0 m M T r i s • HCI~ p H 7.4, 1 0 0
# M p y r i d o x a ] p h o s p h a t e , 10 m M E D T A a n d 1 0 0 # M [ 1 4 C ] s u c c i n y l - C o A (0.1 # C i ) w i t h 1 0 0 m M glycL~le
(e $ ) o r w i t h o u t g l y c i n e (o . . . . . . o), T h e s a m e e x p e r i m e n t s w e r e p e r f o r m e d in t h e p r e s e n c e o f
phenylmethyl s u l f o n y l f i u o r i d e ( I 0 -4 M) w i t h 1 0 0 m M g l y e i n e (m -~) o r w i t h o u t glycine
(u . . . . . . ~)o
423
dent rearrangement to a p r o d u c t which had lost its NH~ group and could n o t
be retained on D o w e x 50.
Experimental demonstration of the pH-dependent rearrangement is shown in
Fig. 4. Aliquots of the acidic eluate of the p r o d u c t of enzymatic degradation of
succinyl-CoA (see legend of Fig. 4) were brought to pH values as shown in the
abscissa, then passed through a D o w e x 50 column. The percent retention on
the column was followed b y radiochemical analysis of the effluent. It was
apparent that rearrangement to N-succinyl-cysteamine occurred readily above
pH 4.0. The most probable mechanism, an internal nucleophilic attack resulting
in the acylation of the NH3 group, is illustrated in Fig. 5. The rearrangement
above pH 4.0 to the more stable N-succinyl-cysteamine, which cannot be
retained b y D o w e x 50 at pH 3.9, explains the biphasic time course of product
formation from succinyl-CoA (Fig. 1). Additional characterization of the
product was obtained by analysis of the thiol content. It was found that the
p r o d u c t which was eluted with 2 M HC1 (see legend of Fig. 4) contained no
thiol i~oups. When the alkaline eluate was treated with ~-mercaptoethanol (see
Materials and Methods) and lyophilized, analysis revealed 1 mol of -SH-group
per mol of succinate. Thus, the failure to detect -SH groups in the alkaline
eluate was readily explained by the oxidation to the disulfide, as shown in Fig.
5.
These results demonstrate that the most rapid enzymatic reaction which
occurred when succinyl-CoA was incubated with a dilute liver homogenate or
mitochondria was the cleavage of succinyl-CoA at the cysteamine site, resulting
in the thioester of cysteamine and succinate. A significant portion of this sub-
I00 -
o
I
'~-o- e--~.~.
\
%
~ 50
I
I
I
\
I I I I r I ~"'0~6--o
1 2 3 4 5 6 7 8 9 I0
pH
~"o-
s o-
Vi °
c1"--. O-
II CH2
CN 2 CH2 ,
] pH 4 4 . 5 I oxidation i I
CH2 - - ~ CH 2 ~ ~ CH a
I (SN[) ] ' [
. ~ G --~-~0 C~---O C~O
"-~ / /
H2N S HN SH NN
| i
CH2-- CH2 CH 2"--- CH2 t
L 42
I E Z
Z. Succlny~-cysteamine thioester
]Z. Succiny[ - N- cystearnine
]Z, D i s u l f i d e or d[mer
Fig. 5. P o s t u l a t e d m e c h a n i s m o f p H - d e p e n d e n t r e a r r a n g e m e n t o f t h e t h i o e s t e r o f s~ceinic a c i d a n d cyste-
a m i n e . T h e t h i o e s t e r o f succinic acid a n d c y s t e a m i n e (I) u n d e r g o e s a n i n t e r n a l n u c l e o p h f l i c a t t a c k b y t h e
t e r m i n a l a m i n o g r o u p at p H 5 . 0 - - 1 0 , r e s u l t i n g in f o r m a t i o n of N - s u c c i n y l - c y s t e a m i n e (H). This t h i o l is
f u r t h e r o x i d i z e d 4o t h e s t a b l e disulfide d i m e r ( I [ D .
which resemble 5-aminolevulinic acid by the Ebert technique [11] from suc-
cinyl-CoA or succinate, respectively.
Acknowledgments
References